Delivery Order SPE2DB24D2106-SPE2DB24FAUUU

Award Date 9/3/24
Potential Completion Date 9/4/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The $1,249.43 award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product, and has a completion date of September 6, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) worth up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) as a delivery order under the SPE2DB program. The $11,513.36 firm fixed-price contract is for the supply of Advair HFA 115-21 MCG inhalers, a specialized pharmaceutical product used to treat respiratory conditions. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,715.40, is for the delivery of ADVAIR HFA 230-21 MCG INHALER 8GM, a specialized pharmaceutical product, to support the medical supply needs of military health facilities. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,385.11 contract is for the delivery of 4565520224 ADVAIR HFA 230-21 MCG INHALER 12GM, with a completion date of August 21, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of pharmaceutical products and medical supplies to the Department...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of pharmaceutical products including medications and medical supplies. The delivery order, valued at $2,494.50, has a completion date of September 13, 2022. This order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group worth up to $499,999,999, which allows the DLA to issue...
This firm fixed-price delivery order, valued at $15,596.22, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) on December 12, 2024. The award is part of a larger single-award Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group, valued at $499,999,999 and valid through November 2026, under the DLA's SPE2DB program. This IDC enables the DLA to issue delivery orders for a comprehensive range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract has a ceiling value of $2,641.60 and covers the supply of a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities worldwide. This...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of various pharmaceutical products and medical supplies. The contract, valued at $31,986.48, has an ultimate completion date of January 25, 2023. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc. under the SPE2DB program, valued at up to...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a Firm Fixed Price Delivery Order valued at $2,798.95 with a period of performance through February 28, 2024. The award was made by the Defense Logistics Agency (DLA) and encompasses the supply of various pharmaceutical products, including medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. This Delivery...
This is a Firm Fixed Price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,479.47 award was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain division to provide a variety of pharmaceutical products to support military health facilities. The delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical...
  • SPE2DB24D2106
    Indefinite Delivery Contract
  • SPE2DB24D2106-SPE2DB24FAUUU
    Delivery Order

This firm fixed-price delivery order award to DMS Pharmaceutical Group Inc., a woman-owned small business, is valued at $2,403.36. The award was made by the Defense Logistics Agency (DLA) under the SPE2DB program, a $499,999,999 indefinite delivery contract that allows the DLA to issue delivery orders for a wide range of pharmaceutical items to support the medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. This delivery order is for 4565662626 ADVAIR HFA 230-21 MCG INHALER 12GM, with a period of performance through September 4, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing both routine and critical medications, including branded, generic, and specialty drugs, as well as medical consumables, to military health facilities globally.

Generated 12/3/24, 9:59 AM